{"id":"W2208369196","doi":"10.1136/gutjnl-2015-309903","title":"IOIBD technical review on endoscopic indices for Crohn's disease clinical trials","year":2015,"lang":"en","type":"article","venue":"Gut","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":191,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"UCB Pharma; Janssen Pharmaceuticals; Takeda Oncology; Genentech; Norgine; Celgene; Achmea; Ironwood Pharmaceuticals, Incorporated; Therakos; Novo Nordisk; Teva Pharmaceutical Industries; Gilead Sciences; Celltrion; Procter and Gamble; Amgen; ActoGeniX; Kyorin Pharmaceutical; Sanofi; Pfizer; Biogen; GlaxoSmithKline; Tillotts Pharma; Dr. Falk Pharma; Shire; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Crohn's disease; Disease; Clinical trial; Delphi method; Inflammatory bowel disease; Gold standard (test); Internal medicine; Endoscopy; Physical therapy; Intensive care medicine; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06494161,0.001875179,0.005823633,0.009719228,0.000740591,0.006151966,0.003003781,0.004350436,0.01077773],"category_scores_gemma":[0.1127756,0.001110742,0.004803833,0.008224849,0.001199354,0.002997294,0.002838054,0.004394107,0.005885866],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006908606,"about_ca_system_score_gemma":0.01173667,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00179949,"about_ca_topic_score_gemma":0.003411287,"domain_scores_codex":[0.9543146,0.02294503,0.01077171,0.001284746,0.009868233,0.0008156094],"domain_scores_gemma":[0.878615,0.06933867,0.01691878,0.003299639,0.02973423,0.002093667],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008166331,0.00007379952,0.0004352208,0.07464739,0.001151464,0.0001301657,0.0001058185,0.0004162402,0.0006016575,0.005887049,0.1732217,0.7425128],"study_design_scores_gemma":[0.0006703108,0.0004904615,0.002893297,0.141792,0.002823141,0.0003992675,0.00005243752,0.0003524619,0.0005718165,0.003892072,0.8459998,0.0000628979],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003080436,0.9543904,0.005394918,0.01393077,0.007178408,0.002593396,0.001158838,0.0001376736,0.01490737],"genre_scores_gemma":[0.004870945,0.9254266,0.02412475,0.01998825,0.007876296,0.00738905,0.0022276,0.0002490945,0.007847382],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.06494161,"threshold_uncertainty_score":0.3434482,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1263077064082742,"score_gpt":0.4382119991334631,"score_spread":0.3119042927251889,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}